Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis: Mortality after bleeding vs MI in CAD patients
R Piccolo, A Oliva, M Avvedimento… - …, 2021 - pmc.ncbi.nlm.nih.gov
Background Bleeding is the principal safety concern of antithrombotic therapy and occurs
frequently among patients with coronary artery disease (CAD). Aims We aimed to evaluate …
frequently among patients with coronary artery disease (CAD). Aims We aimed to evaluate …
Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients
Background Bleeding following percutaneous coronary intervention has important
prognostic implications. The Academic Research Consortium (ARC) recently proposed a list …
prognostic implications. The Academic Research Consortium (ARC) recently proposed a list …
Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention
P Généreux, G Giustino, B Witzenbichler… - Journal of the American …, 2015 - jacc.org
Background: The incidence, predictors, and prognostic impact of post-discharge bleeding
(PDB) after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) …
(PDB) after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) …
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event …
Aims Dual antiplatelet therapy reduces non-fatal ischaemic events after acute coronary
syndrome (ACS) but increases bleeding to a similar extent. We sought to determine the …
syndrome (ACS) but increases bleeding to a similar extent. We sought to determine the …
Clinical outcomes of concomitant use of proton pump inhibitors and dual antiplatelet therapy: a systematic review and meta-analysis
H Guo, Z Ye, R Huang - Frontiers in Pharmacology, 2021 - frontiersin.org
Background: The safety and efficacy associated with the use of proton pump inhibitors (PPIs)
by patients with coronary artery disease receiving dual antiplatelet therapy (DAPT) remain …
by patients with coronary artery disease receiving dual antiplatelet therapy (DAPT) remain …
3-or 1-month DAPT in patients at high bleeding risk undergoing everolimus-eluting stent implantation
Objectives The aim of this study was to evaluate 2 abbreviated dual-antiplatelet therapy
(DAPT) regimens in patients at high bleeding risk (HBR) undergoing percutaneous coronary …
(DAPT) regimens in patients at high bleeding risk (HBR) undergoing percutaneous coronary …
Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials
Background: New randomized, controlled trials have become available on oral P2Y12
inhibitors in acute coronary syndrome. We aimed to evaluate current evidence comparing …
inhibitors in acute coronary syndrome. We aimed to evaluate current evidence comparing …
Assessing the risks of bleeding vs thrombotic events in patients at high bleeding risk after coronary stent implantation: the ARC–high bleeding risk trade-off model
P Urban, J Gregson, R Owen, R Mehran… - JAMA …, 2021 - jamanetwork.com
Importance Patients who are candidates for percutaneous coronary intervention (PCI) and
are at high bleeding risk constitute a therapeutic challenge because they often also face an …
are at high bleeding risk constitute a therapeutic challenge because they often also face an …
Bleeding-related deaths in relation to the duration of dual-antiplatelet therapy after coronary stenting
T Palmerini, L Bacchi Reggiani, D Della Riva… - Journal of the American …, 2017 - jacc.org
Background: Although some randomized controlled trials (RCTs) and meta-analyses have
suggested that prolonged dual-antiplatelet therapy (DAPT) may be associated with …
suggested that prolonged dual-antiplatelet therapy (DAPT) may be associated with …
Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction
Aims Guidelines differ in their recommendations on therapy to prevent gastrointestinal
bleeding for patients treated with dual antiplatelet treatment (DAPT). We sought to …
bleeding for patients treated with dual antiplatelet treatment (DAPT). We sought to …